Elevated HPRT mutation frequencies in aflatoxin-exposed residents of Daxin, Qidong County, People's Republic of China

Carcinogenesis

Volumn 20, Issue 11, 1999, Pages 2181-2184

  Wang, Sophia S ^a   O'Neill, J Patrick ^c   Qian, Geng Sun ^e   Zhu, Yu Rong ^f   Wang, Jia Bin ^f   Armenian, Haroutune ^a   Zarba, Audrey ^b   Wang, Jia Sheng ^b   Kensler, Thomas W ^b   Cariello, Neal F ^d,g   Groopman, John D ^b,f   Swenberg, James A ^d  

^a JOHNS HOPKINS UNIVERSITY   (United States)

^b The Johns Hopkins University   (United States)

^c UNIVERSITY OF VERMONT   (United States)

^d UNIVERSITY OF NORTH CAROLINA   (United States)

^e SHANGHAI CANCER INSTITUTE   (China)

^f QIDONG LIVER CANCER INSTITUTE   (China)

^g GLAXOSMITHKLINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AFLATOXIN; ALBUMIN; HEPATITIS B SURFACE ANTIGEN; HYPOXANTHINE PHOSPHORIBOSYLTRANSFERASE;

ADULT; ARTICLE; BLOOD LEVEL; CHINA; CONTROLLED STUDY; DNA ADDUCT; ENVIRONMENTAL EXPOSURE; FEMALE; HIGH RISK POPULATION; HUMAN; HUMAN CELL; MALE; MUTATION RATE; NORMAL HUMAN; PRIORITY JOURNAL; SOMATIC MUTATION; T LYMPHOCYTE;

EID: 0032724267     PISSN: 01433334     EISSN: None     Source Type: Journal    
DOI: 10.1093/carcin/20.11.2181     Document Type: Article

References (41)

1. Linsell, C.A. and Peers, F.G. (1977) Aflatoxin and liver cell cancer. Trans. R. Soc. Trop. Med. Hyg., 71, 471.
2. Linsell, C.A. (1980) Incidence of hepato-carcinoma in relationship to aflatoxin intake. Arch. Toxicol., Suppl. 3, 13-18.
3. OnYemelukwe, C.G., Nirodi, C. and West, C.E. (1980) Aflatoxin B1 in hepatocellular carcinoma. Trop. Geogr. Med, 32, 237-240.
4. Decker, R.H. and Kuhns, M.C. (1986) Epidemiology of primary liver cancer. Biochem. Mol. Epidemiol. Cancer, 40, 227-231.
5. Groopman, J.D., DeMatos, P., Egner, P.A., Love-Hunt, A. and Kensler T.W. (1992) Molecular dosimetry of urinary aflatoxin-N7-guanine and serum aflatoxin albumin adducts predicts chemoprotection by 1,2-dithiole-3-thione in rats. Carcinogenesis, 13, 101-106.
6. Groopman, J.D. and Skipper, P.L. (1991) Molecular Dosimetry and Human Cancer: Analytical, Epidemiological and Social Considerations. CRC Press, Boca Raton, FL.
7. Bailey, G.S. (1994) Role of aflatoxin-DNA adducts in the cancer process. In The Toxicology of Aflatoxins: Human Health, Veterinary and Agricultural Significance. Academic Press, New York, NY, pp. 137-199.
8. Busby, W.F. and Wogan, G.N. (1984) Aflatoxins. In Searle, C.E. (ed), Chemical Carcinogens, 2nd Edn. American Chemical Society, Washington, DC, pp. 945-1136.
9. Dragan, Y.P. and Pitot, H.C. (1994) Aflatoxin carcinogenesis in the context of the multistage nature of cancer. Toxicol. Aflatoxins, ??, 179-199.
10. Hall, A.J. and Wild, C.P. (1994) Epidemiology of aflatoxin-related disease. In The Toxicology of Aflatoxins: Human Health, Veterinary and Agricultural Significance. Academic Press, New York, NY, pp. 233-254.
11. IARC (1994) IARC Monographs on the Evaluation of Carcinogenic Risks to Humans, Vol. 59. Hepatitis Viruses. IARC, Lyon.
12. Gan, L.S., Skipper, P.L., Peng, X.C., Groopman, J.D., Chen, J.S., Wogan, G.N. and Tannenbaum, S.R. (1988) Serum albumin adducts in the molecular epidemiology of aflatoxin carcinogenesis: correlation with aflatoxin B1 intake and urinary excretion of aflatoxin M1. Carcinogenesis, 9, 1323-1325.
13. Groopman, J.D., Zhu, J., Donahue, P.R., Pikul, A., Zhang, L., Chen, J. and Wogan, G.N. (1992) Molecular dosimetry of urinary aflaloxin-DNA adducts in people living in Guangxi Autonomous Region, People's Republic of China. Cancer Res., 52, 45-52.
14. Ross, R.K., Yuan, J.M., Yu, M.C., Wogan, G.N., Qian, G.S., Tu, J.T., Groopman, J.D., Gao, Y.T. and Henderson, B.E. (1992) Urinary aflatoxin biomarkers and risk of hepatocellular carcinoma. Lancet, 339, 943-946.
15. Groopman, J.D. and Kensler, T.W. (1993) Molecular biomarkers for human chemical carcinogen exposures. Chem. Res. Toxicol., 6, 764-770.
16. Groopman, J.D., Roebuck, B.C. and Kensler, T.W. (1994) Carcinogen-DNA and protein adducts as intermediate biomarkers for human chemoprotection trials. In Jacobs, M. (ed.) Diet and Cancer: Markers, Prevention and Treatment. Plenum Press, New York, NY, pp.149-160.
17. Qian, G., Ross, R.K., Yu, M.C., Yuan, J., Henderson, B.E., Wogan, G.N. and Groopman, J.D. (1994) A follow-up study of urinary markers of aflatoxin exposure and liver cancer risk in Shanghai, People's Republic of China. Cancer Epidemiol. Biomarkers Prev., 3, 3-10.
18. Lambert, B., Anderson, B., He, S.M., Marcus, S. and Steen, A.M. (1992) Molecular analysis of mutation in the human gene for hypoxanthine phosphoribosyltransferase. Mol. Genet. Med., 2, 161-188.
19. Albertini, R.J., Nicklas, J.A., Fuscoe, J.C., Skopek, T.R., Branda, R.F. and O'Neill, J.P. (1993) In vivo mutations in human blood cells: biomarkers for molecular epidemiology. Environ. Health Perspect., 99, 135-141.
20. Albertini, R.J., Nicklas, J.A. and O'Neill, J.P. (1993) Somatic cell gene mutations in humans: biomarkers for genotoxicity. Environ. Health Perspect., 101 (suppl. 3), 193-201.
21. Cariello, N.F. and Skopek, J.R. (1993) Analysis of mutations occurring at the human HPRT. J. Mol. Biol., 231, 41-57.
22. Cariello, N.F. and Skopek, T.R. (1993) In vivo mutation at the human HPRT locus. Trends Genet., 9, 322-326.
23. Cariello, N.F., Cui, L. and Skopek, T.R. (1994) In vitro mutational spectrum of aflatoxin B1 in the human hypoxanthine guanine phosphoribosyl transferase gene. Cancer Res., 54, 4436-4441.
24. Cariello, N.F. (1994) Database and software for the analysis of mutations at the human HPRT gene. Nucleic Acids Res., 22, 3547-3548.
25. Cariello, N.F. (1994) Software for the analysis of mutations at the human HPRT gene. Mulat. Res., 312, 173-185.
26. Albertini, R.J. and O'Neill, J.P. (1995) Human monitoring for somatic mutation in human. Environ. Mutagen., 17, 1-25.
27. Hakoda, M., Hirai, Y., Kyoizumi, S. and Akiyama, M. (1989) Molecular analysis of in vivo HPRT mutant T cells from atomic bomb survivors. Environ. Mol. Mutagen., 13, 25-33.
28. Branda, R.F., Sullivan, L.M., O'Neill, J. Falta, M.T., Nicklas, J.A., Hirsch, B., Vacek, P.M. and Albertini, R.J. (1993) Measurement of HPRT mutant frequencies in T-lymphocytes from healthy human populations. Mutat. Res., 285, 267-279.
29. O'Neill, J.P., McGinniss, M.J., Berman, J.K., Sullivan, L.M., Nicklas, J.A. and Albertini, R.J. (1987) Refinement of a T-lymphocyte cloning assay to quantify the in vivo thioguanine-resistant mutant frequency in humans. Mutagenesis, 2, 87-94.
30. O'Neill, J.P., Sullivan, L.M., Booker, J.K., Pornelos, B.S., Falta, M.T., Greene, C.J. and Albertini, R.J. (1989) Longitudinal study of the in vivo HPRT mutant frequency in human T-lymphocytes as determined by a cell cloning assay. Environ. Mol. Mutagen., 13, 289-293.
31. Wang, J., Qian, G., Zarba, A. et al. (1996) Temporal patterns of aflatoxin-albumin adducts in hepatitis B surface antigen positive and negative residents of Daxin, Qidong County, People's Republic of China. Cancer Epidemiol. Biomarkers Prev., 5, 253-261.
32. Zhu, Y., Chen, H. and Huang, X. (1990) 20 hepatocellular carcinoma in Qidong County. In Primary Liver Cancer, China Academic Publishers, Beijing, China, pp.201-222.
33. Jacobson, L.P., Zhang, B.C., Zhu, Y.R. et al. (1997) Oltipraz chemoprevention trial in Qidong, PRC: study design and clinical outcomes. Cancer Epidemiol. Biomarkers Prev., 6, 257-265.
34. Kensler, T.W., He, X., Otieno, M. et al. (1998) Oltipraz chemoprevention trial in Qidong, P.R.C.: modulation of serum aflatoxin albumin adduct biomarkers. Cancer Epidemiol. Biomarkers Prev., 7, 127-134.
35. Nicklas, J.A., O'Neill, J.P., Sullivan, L.M., Hunter, T.C., Allegretta, M., Chastenay, B.F., Libbus, B.L. and Albertini, R.J. (1988) Molecular analyses of in vivo hypoxanthine-guanine phosphoribosyl transferase mutations in human T-lymphocytes: II. Demonstration of a clonal amplification of HPRT mutant T-lymphocytes in vivo. Environ. Mol. Mutagen., 12, 271-284.
36. Nicklas, J.A., Hunter, T.C., O'Neill, J.P. and Albertini, R.J. (1989) Molecular analyses of in vivo HPRT mutations in human T-lymphocytes: III. Longitudinal study of HPRT gene structural alterations and T-cell clonal origins. Mutat. Res., 215, 147-160.
37. Albertini, R.J., O'Neill, J.P., Nicklas, J.A., Recio, L. and Skopek, T.R. (1990) HPRT mutations in vivo in human T-lymphocytes: frequencies, spectra and clonality. Mulat. Environ., 340C, 15-24.
38. Chen, Q., Yun, Z., Shen, Q., Jin, B., Tang, J., Fan, M. and Min, J. (1992) A 14-year prospective study on the risk factors of liver cancer of high risk population with liver disease history in Qidong County. J. Nanjing Railway Med. Coll., 9, 152-156.
39. Kuang, S.Y., Frang, X., Lu, P.X., Zhang, Q.N., Wu, Y., Wang, J.B., Zhu, Y.R., Groopman, J.D., Kensler, T.W. and Qian, G.S. (1996) Aflatoxin-albumin adducts and risk for hepatocellular carcinoma in residents of Qidong, People's Republic of China. Proc. Am. Assoc. Cancer Res., 371, A1216 (abstract).
40. Boise, L.H., Min, A.J. and Thompson, C.B. (1995) Receptors that regulate T-cell susceptibility to apoptotic cell death. Ann. NY Acad. Sci., 766, 70-80.
41. Russell, J.H. (1995) Activation-induced death of mature T cells in the regulation of immune responses. Curr. Opin. Immunol., 7, 382-388.